For R&D Laboratories & OEM Formulators

Technical data &
evaluation samples

Technical data sheets, safety documentation, regulatory reference files, and evaluation samples (50–100g) are available at no charge to qualified R&D laboratories and formulation OEMs. No purchase commitment required.

Request documentation & samples
We respond within 2 business days.

Samples shipped to qualified laboratories. Commercial pricing discussed separately upon request.

Hydroxyapatite-LC: technical overview

Manufactured under Japanese Quasi-Drug Raw Material standards with complete lot traceability and certificate of analysis for every batch.

Material & physical properties
INCI name
Hydroxyapatite
Chemical formula
Ca₁₀(PO₄)₆(OH)₂
Type
Nano-hydroxyapatite (nHAP)
Particle size
20–80 nm
Appearance
White to off-white powder
Ca/P molar ratio
1.67 (stoichiometric)
Origin
Mineral-derived (limestone), Japan
Crystal structure
Hexagonal — matches natural enamel
Quality & regulatory status
Manufacturing standard
Japanese Quasi-Drug Raw Material
GHS classification
Non-hazardous (confirmed)
EU SCCS status
Safe in oral care ≤29.5%
Japan approval
Anti-cavity active since 1993
Patent status
Patented manufacturing process (Japan)
Lot traceability
Complete — CoA per batch
Particle consistency
Controlled morphology, minimal lot variation
Quality oversight
100% manufactured in Japan

Why manufacturing process
determines functional performance

Both Hydroxyapatite-LC and general mineral-derived HAP start from limestone. The difference is everything that happens after — and it determines whether the material performs in a formulation claim or just appears on an ingredient list.

Technical comparison chart: General mineral-derived hydroxyapatite vs Hydroxyapatite-LC. Comparing raw material origin, manufacturing process, particle consistency, quality standard, purity control, GHS safety, designed application, and quality assurance.
Figure 01

The critical difference lies not in the source rock, but in the precision of the manufacturing process and the purpose of the design. General industrial HAP is engineered for bulk application; Hydroxyapatite-LC is specifically designed and tested for cosmetic and oral care performance claims.

What we send to qualified enquiries

DOC — 01

Technical Data Sheet

Full physical and chemical specifications, particle size data, solubility, pH in suspension, bulk density, and formulation compatibility parameters.

Available on request
DOC — 02

Safety Data Sheet (SDS)

GHS-compliant safety data sheet documenting hazard classification (non-hazardous), handling requirements, first aid, and disposal information.

Available on request
DOC — 03

Certificate of Analysis

Lot-specific CoA confirming purity, particle size distribution, heavy metal limits, and quality parameter compliance for manufacturing batch traceability.

Per lot — on request
DOC — 04

Regulatory Reference File

Summary of regulatory status across key markets: Japan (Quasi-Drug), EU (SCCS assessment reference), and relevant INCI documentation for formulation dossiers.

Available on request
DOC — 05

Research Reference Summary

Curated reference list of peer-reviewed publications covering remineralisation, bacterial adsorption, sensitivity reduction, and whitening efficacy — with relevance notes per application pillar.

Available on request
SAMPLE

Evaluation Sample (50–100g)

Physical powder sample for in-house formulation testing, stability assessment, and sensory evaluation. Shipped to qualified R&D laboratories. No purchase commitment required for evaluation.

Qualified labs — on request